Skip to content

Effects of Combined Physical-cognitive Training on Cognitive Function in MCI

Synergistic Effects of Combined Physical-cognitive Training on Cognitive Function in Individuals With Mild Cognitive Impairment (MCI): A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03805620
Enrollment
128
Registered
2019-01-15
Start date
2019-03-18
Completion date
2021-06-28
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

mild cognitive impairment, combined physical-cognitive training, BDNF, mitochondrial function, cognitive function

Brief summary

The present study aims to investigate the effects of combined physical-cognitive training on cognitive function as well as peripheral BDNF level and mitochondrial function of individuals with MCI. It is hypothesized that: 1) the combined physical-cognitive training program will be superior to the physical and cognitive training program alone; and 2) the degree of cognitive improvement will be positively correlated with the improvement of plasma BDNF and mitochondrial function.

Detailed description

Recent research suggests that the benefits of combined physical-cognitive training may be greater than either physical or cognitive training alone. Nevertheless, this synergistic effect has been demonstrated mainly in cognitively intact older adults. Studies examining the effects of combined physical-cognitive training in older adults with MCI are scarce and show mixed results. Moreover, few studies have determined the effects of the combined training on peripheral brain-derived neurotrophic factor (BDNF) and mitochondrial function. Thus, the present study aims to investigate the effects of combined physical-cognitive training on cognitive function as well as peripheral BDNF level and mitochondrial function of individuals with MCI. The present study will provide insight into the interplay among the training program, peripheral BDNF concentration, mitochondrial function, and cognitive function. Importantly, the findings will have clinical implication regarding the training program that is feasible and effective in improving cognitive function of older adults with MCI which ultimately will have great impact on public health as this population is at high risk of progression to AD.

Interventions

OTHERCombined physical-cognitive training

combined physical-cognitive training

OTHERPhysical training

Multi-component physical exercise

OTHERCognitive training

cognitive training

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* meet criteria for mNCD (mild neurocognitive disorders), previously known as MCI, based on the recent DSM-V (Diagnostic Statistical Manual-V) criteria * comprehend instructions and willing to participate * able to comply with the study schedule and procedures * not taking any medications for their cognition and not planning to start medications during the study trial

Exclusion criteria

* presence of medical conditions that would be unsafe to exercise * diagnosed with other neurological conditions (e.g. Parkinson's disease, Stroke, Multiple Sclerosis, AD) that affect cognition and mobility * presence of depressive symptoms * presence of acute or/and chronic disease that could not be controlled (e.g. Arthritis, Asthma, Hypertension, Diabetes mellitus, Coronary artery disease) * exercise regularly (at least 30 min/day, 3 days/week)

Design outcomes

Primary

MeasureTime frameDescription
change from baseline Alzheimer's Disease Assessment- cognitive subscale at 3 months3 monthsAlzheimer's Disease Assessment-cognitive subscale will be assessed at baseline and 3 months. The total scores range from 0-70, with higher scores (≥ 18) indicating greater cognitive impairment.
change from baseline Rey auditory verbal learning score at 3 months3 monthsMemory will be assessed using Rey auditory verbal learning test.
change from baseline Trail Making B-A score at 3 months3 monthsExecutive function will be assessed using Trail Making Test part B-A.
change from baseline brain-derived neurotrophic factor level at 3 months3 monthsLevel of plasma brain-derived neurotrophic factor (BDNF) will be determined.

Secondary

MeasureTime frameDescription
change from baseline Digit Span score at 3 months3 monthsAttention will be assessed using Digit Span forward-backward test.
change from baseline cellular oxidative stress level at 3 months3 monthsMitochondrial function will be determined from cellular oxidative stress level
change from baseline stepping response time at 3 months3 monthsProcessing speed will be measured using stepping response time.
change from baseline time to complete Timed Up and Go at 3 months3 monthsFunctional ability will be assessed using time to complete Timed Up and Go (TUG).
change from baseline physiological profile assessment score at 3 months3 monthsFall risk will be assessed using the physiological profile assessment. The test consists of five sensorimotor and balance measures including visual contrast sensitivity, proprioception, quadriceps muscle strength, hand reaction time, and postural sway. The five PPA components are weighted to compute a composite z-score distribution with high scores indicating increased fall risk.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026